ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Astellas Cuts OSI Operations

by Lisa M. Jarvis
August 9, 2010 | APPEARED IN VOLUME 88, ISSUE 32

Just a month after completing its acquisition of OSI Pharmaceuticals, Japanese drugmaker Astellas is already making cuts at the biotech firm. Astellas plans to close OSI’s Ardsley and Melville, N.Y., facilities by June 2011, moves that will affect about 150 jobs. OSI’s 90-worker site in Farmingdale, N.Y., and office in Cedar Knolls, N.J., will be spared, but they could be affected once the integration process is completed.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment